EUVIMEDEUVIMED entdecken
Crossref

Characterizing tumor-infiltrating group 1 innate lymphoid cells in PyMT breast tumors

Douglas C Chung, Alisha R Elford, Nicolas Jacquelot

Methods in Cell Biology · 2025

DOI: 10.1016/bs.mcb.2024.03.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods in Cell Biology, 2025. Verfasst von Douglas C Chung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Toronto, Toronto, ON, Canada; Tumor immunotherapy program, Princess Margaret Cancer Centre, University Health…. Hauptthemen laut MEDLINE: Immunity, Innate, Lymphocytes, Tumor-Infiltrating, Breast Neoplasms, Mammary Neoplasms, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Alberta Cancer Foundation, Arnie Charbonneau Cancer Institute, University of Calgary, Canadian Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most common cancer in women and continues to have a significant impact in cancer-associated deaths worldwide. Investigating the complex roles of infiltrating immune subsets within the tumor microenvironment (TME) will enable a better understanding of disease progression and reveal novel therapeutic strategies for patients with breast cancer. The mammary-specific expression of polyomavirus middle T oncoprotein (MMTV-PyMT) was first established in 1992 by William Muller and is the most commonly used genetically engineered mouse model (GEMM) for breast cancer research. Innate lymphoid cells (ILCs) are composed of a diverse family of effector cells known to play important roles in defense against pathogens, tissue homeostasis, and tumor immunity. In mice, group 1 ILCs are composed of NK cells and ILC1s, which have been shown to have differential roles within the TME. Here, we provide a detailed methodology in characterizing tumor-infiltrating NK cells and ILC1s in MMTV-PyMT breast tumor model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateLymphocytes, Tumor-InfiltratingBreast NeoplasmsMammary Neoplasms, ExperimentalLymphocytesAnimalsFemaleMiceKiller Cells, NaturalTumor MicroenvironmentHumansMammary Tumor Virus, Mouse

Stichwörter der Autor:innen

Breast cancerILC1Innate lymphoid cellsNK cellsPyMTTumor microenvironment

Autor:innen und Institutionen

  • Department of Immunology, University of Toronto, Toronto, ON, Canada; Tumor immunotherapy program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Tumor immunotherapy program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, Unive…

Förderung

  • Alberta Cancer Foundation
  • Arnie Charbonneau Cancer Institute, University of Calgary
  • Canadian Cancer Society

Zitieren

APA

Chung, D. C., Elford, A. R., & Jacquelot, N. (2025). Characterizing tumor-infiltrating group 1 innate lymphoid cells in PyMT breast tumors. Methods in Cell Biology. https://doi.org/10.1016/bs.mcb.2024.03.008

Vancouver

Chung DC, Elford AR, Jacquelot N. Characterizing tumor-infiltrating group 1 innate lymphoid cells in PyMT breast tumors. Methods in Cell Biology. 2025. doi:10.1016/bs.mcb.2024.03.008

BibTeX
@article{Chung2025,
  author = {Chung, Douglas C and Elford, Alisha R and Jacquelot, Nicolas},
  title = {Characterizing tumor-infiltrating group 1 innate lymphoid cells in PyMT breast tumors},
  journal = {Methods in Cell Biology},
  year = {2025},
  doi = {10.1016/bs.mcb.2024.03.008}
}
Kostenlos starten →